Pure Global
NCT06421415

Long Term Effect of AIT in Children

Odense University Hospital·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Allergy in Children
Drug/Device/Intervention
Allergen Immunotherapy Extract
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
Odense University Hospital
Location
Odense,Odense, Denmark
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
May 01, 2037
Enrollment
100 participants
Primary outcome

Effect of immunotherapy 5 years after end of treatment

Summary

The present study will investigate the long term effect of allergen immunotherapy in a
 real-life study in children with allergy undergoing subcutaneous or sublingual immunotherapy
 with grass pollen, birch, house dust mites or venom.

ICD-10 classifications
Allergy, unspecifiedPersonal history of allergy to other anti-infective agentsPersonal history of allergy, other than to drugs and biological substancesPersonal history of allergy to other drugs, medicaments and biological substancesPersonal history of allergy to unspecified drugs, medicaments and biological substances
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06421415
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06421415 through Pure Global AI's free database. This phase not specified trial is sponsored by Odense University Hospital and is currently Recruiting. The study focuses on Allergy in Children. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.